Immix Biopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $96 | $0 |
Gross Profit | -79 | -59 | 48 | -25 |
EBITDA | -6,717 | -4,682 | -4,945 | -7,369 |
EBIT | -4,742 | -4,987 | -7,394 | |
Net Income | -6,622 | -4,542 | -4,812 | -7,149 |
Net Change In Cash | 0 | 0 | 96 | 0 |
Free Cash Flow | -5,437 | -1,752 | -1,983 | -4,307 |
Cash | 11,637 | 15,921 | 17,681 | 19,690 |
Basic Shares | 29,983 | 29,701 | 27,540 | 29,424 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-89,517 | $0 |
Gross Profit | -115 | -5 | -89,519 | -2 |
EBITDA | -21,541 | -16,135 | -8,216 | -1,349 |
EBIT | -21,657 | -16,141 | -8,218 | -1,352 |
Net Income | -21,613 | -15,426 | -8,229 | -24,383 |
Net Change In Cash | 0 | 0 | -89,517 | 0 |
Free Cash Flow | -15,772 | -11,423 | -7,408 | -1,590 |
Cash | 17,681 | 17,509 | 13,436 | 17,644 |
Basic Shares | 28,285 | 17,341 | 13,228 | 13,228 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.22 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.25 |
